The marketing authorisations for three generic drugs signifying advances in cancer treatment will considerably benefit thousands of patients by improving access, ensuring affordability
Themis will market this drug with the brand name REMITHEM.
The company has launched its new range of 25 allopathy ophthalmic products including GUERIMOD, GUERIPRED, BIMATO MST etc. for curing various diseases related to eyes
Diagnostic imaging will become an increasingly vital process in healthcare
AI-based medical imaging equipment firm Lunit has signed a contract to supply AI-based breast cancer screening solution “Lunit Insight MMG”
The cardiomyopathies market in the 68M is set to grow at a CAGR of 12.1%
Global pharmaceutical company having a surgical business concept incepted in Dubai
Empagliflozin is a novel sodium glucose co-transporter-2 (SGLT-2) inhibitor, which is useful for improving glycaemic control in adults with type-2 diabetes mellitus.
To focus on providing safer burn treatments for women and armed forces
Silodosin capsules treat signs and symptoms of an enlarged prostate gland
Subscribe To Our Newsletter & Stay Updated
